Pharma Patrick Choay discusses his first foray into the pharmaceutical business world, talks about the highlights of his long and interesting career, his balanced partnership strategy for the Choay Group and the importance of cultivating a business environment conducive to entrepreneurship. What led you to launch your own group, Patrick Choay…
Pharma Abbvie has taking a leading role in the Egyptian pharmaceutical industry by bringing their new all-oral hepatitis C treatment to Egypt, the country with the highest prevalence of the disease in the world, making the company a major stakeholder in the country’s highest priority healthcare issue. How would you assess…
Pharma Marc-Antoine Lucchini, the president-general manager of Sanofi France, talks about their unprecedented number of new molecules and innovations soon to be launched. He also explains the need to focus on the long-term impact of pricing and why the way Sanofi performs in France acts as a model for other affiliates across…
Pharma Aurélien Chaufour reveals how Anjac Health and Beauty has developed with a focus on innovation and industrial know-how since its creation in 2008 and how he today has four companies that are experts in the fields of health, hygiene and beauty. Chaufour also reveals why there is long-term future for…
Pharma Wiebke Rieb describes Pfizer’s commitment to ensuring patient access to the necessary treatments and working with all stakeholders to further strengthen the Dutch healthcare system, as well as the company’s community projects. Ms. Rieb, you became head of the Dutch affiliate in April 2014. What have been your main strategic…
Pharma Enrico Allievi, President of the Italian OTC (Over The Counter) association, Assosalute, talks about the state of the OTC market in Italy, as well as the association’s role in creating value for its members and his outlook for the next five years. Enrico, to start off, could you explain Assosalute’s…
Pharma The CEO of Medicen Paris Region, the biopharma cluster for the Paris region, discusses her vision to develop a world-class cluster and act as a catalyst for innovation; her international partnership strategy and how her diverse background in engineering, medicine and a variety of companies has equipped her to lead…
Pharma Théa’s Jean-Frederic Chibret reveals how as a company focused purely on ophthalmology, they have the expertise to focus on niche areas that big pharma companies neglect; how they are the third largest pharma ophthalmic company in Europe, and the only pan-European ophthalmic company to have its headquarters on the continent, and…
Pharma Mr Truelle, the CEO of CDM Lavoisier, a company specialized in the pharmaceutical manufacturing of injectable solutions, reveals that one third of the French population could receive one of the company’s products each year, talks about their extremely promising partnership with the Danish company Coloplast, and why partners from beyond…
Pharma Bernard Vanhove, CEO and Maryvonne Hiance, Chairman of Effimune, an immune regulation biotech, discuss their novel approach to developing immunotherapies, their partnership and commercialization strategies, their perspective on the landscape of immunotherapy as well as the evolution of the French biotech environment, and finally, their mission to position Effimune as…
Pharma Dr. Anna Maria Porrini, President of Boehringer Ingelheim Italy shares her vision for the company, how she intends to achieve it and where she sees opportunities for the company’s success in the market. Dr. Porrini, since we last spoke in 2009, Boehringer Ingelheim Italy has weathered the crisis and emerged…
Pharma Antonino Reale, who has managed Daiichi-Sankyo Italy for the last 12 years, explains the reasoning and strategy behind the company’s almost total restructuring in 2013, including how this has given birth to a new, more agile organization with high engagement amongst its employees, as well as where he believes the…
See our Cookie Privacy Policy Here